NeoGenomics

NeoGenomics, based in Fort Myers, Florida, and listed as NEO, is a cancer-focused reference laboratory for immunohistochemistry, FISH, flow cytometry and next-generation sequencing, serving community oncology and pharmaceutical companies. It has the broadest oncology test menu among independent laboratories, offers the RaDaR measurable residual disease assay from its Inivata acquisition, and runs a pharma services division. OnCo links it to reference laboratories, MRD testing and comprehensive genomic profiling, and to RaDaR and Inivata. Whether a cancer-only laboratory can hold its ground against the national reference laboratories and specialist genomics companies is the open question. RaDaR has its own page.